Method for co-immobilizing glutamate decarboxylase and coenzyme pyridoxal phosphate thereof
By covalently binding glutamate decarboxylase on Fe3O4@PDA magnetic nanoparticles and forming a PEI network, electrostatic adsorbing PLP, the problem of coenzyme PLP loss is solved, the reusability and stability of the enzyme is improved, and the production cost is reduced , realizes efficient synthesis of GABA.
Patent Information
- Application Number
- CN202410934129.3
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-12
- Publication Date
- 2024-11-22
AI Technical Summary
The existing immobilized glutamate decarboxylase methods fail to immobilize the coenzyme pyridoxal phosphate (PLP) together, resulting in easy loss, increasing production costs and difficulty in separation and purification.
Fe3O4@PDA magnetic nanoparticles are used as carrier to covalently bind to glutamate decarboxylase (GAD) through the catechol bond on the PDA, and a PEI network is formed on the Fe3O4@PDA@GAD surface, using the positive charge of the PEI surface. Electrostatically adsorbs negatively charged PLP to achieve co-fixation of GAD and its coenzyme PLP.
It realizes storage and prevention of loss of PLP, reduces the need for subsequent addition of PLP, improves the reusability and stability of enzymes, reduces production costs, overcomes the difficulties of separation and purification, and improves the economic feasibility of industrial production. .
Smart Images

Figure SMS_1 
Figure HDA0004940764630000011 
Figure HDA0004940764630000012
Abstract
Description
Technical Field
[0001] The invention relates to an immobilization method, in particular to a method for co-immobilizing glutamate decarboxylase and its coenzyme pyridoxal phosphate. Background Art
[0002] The structural formula of γ-aminobutyric acid (GABA) is shown in Formula I. Its relative molecular mass is 103.12, and its molecular formula is C4H9NO2. It is a white crystalline powder and is an important inhibitory neurotransmitter in the central nervous system of mammals. It is used to treat nervous system diseases. γ-aminobutyric acid is formed by decarboxylation of α-aminoglutaric acid. It is a non-protein amino acid with four carbon atoms and is widely distributed in plants, animals and microorganisms.
[0003] Formula I: GABA structure There are many methods for producing GABA. Currently, the commonly used synthesis methods are as follows: ① Chemical synthesis method for preparing GABA. Due to the high cost, many side reactions and great environmental pollution of chemical synthesis of GABA, its application in the food and pharmaceutical industries is limited. ② Plant enrichment method for synthesizing GABA. Although it can be used in the food and pharmaceutical industries, it has low yield and long cycle. ③ Microbial fermentation method for preparing GABA is to produce GABA with microorganisms as the main body. It has the advantages of low environmental pollution, low cost, high product yield, mild reaction conditions and short production cycle. However, microbial fermentation method has the disadvantages of easy pollution, long cycle, poor repeatability, cumbersome later extraction and high cost of treatment and purification in actual fermentation production. ④ Enzyme conversion method for preparing GABA. This method is safe and gentle to operate, easy to separate from the reaction system and large-scale production. It has been widely used. However, free enzymes have the disadvantages of being mixed into the product after participating in the reaction and cannot be recycled or reused, which increases the difficulty of separation and purification and the production cost of enterprises.
[0004] After being immobilized, glutamate decarboxylase can maintain its catalytic properties. Due to its characteristics of easy separation, repeated use, and controllable operation process, it has received widespread attention from researchers in recent years. However, the existing immobilized enzymes only immobilize glutamate decarboxylase, and do not immobilize the coenzyme PLP together, which makes the coenzyme easy to lose. Therefore, PLP needs to be continuously added during use. The exogenous addition of PLP not only increases the difficulty of downstream separation and purification, but also increases the cost of PLP procurement for enterprises. Summary of the invention
[0005] The purpose of the present invention is to provide a method for co-fixing glutamate decarboxylase and its coenzyme pyridoxal phosphate, so as to co-fix glutamate decarboxylase and its coenzyme to catalyze L-glutamate sodium to synthesize GABA, thereby increasing the reusability of the enzyme, reducing production costs and increasing economic benefits.
[0006] The present invention firstly uses Fe3O4@PDA magnetic nanoparticles as a carrier, and covalently binds glutamate decarboxylase (GAD) to the carrier surface through the catechol bond on PDA and the amino group and thiol group of GAD; then, polyethyleneimine (PEI) is grafted on the surface of Fe3O4@PDA@GAD to form a PEI network, and GAD is wrapped inside to obtain Fe3O4@PDA@PEI@GAD; finally, the positive charges carried by a large number of amino groups on the surface of PEI are used to electrostatically adsorb negatively charged pyridoxal phosphate (PLP), so as to achieve co-fixation of GDA and its coenzyme PLP, and obtain Fe3O4@PDA@PEI@GAD&PLP.
[0007] The present invention adopts the following technical solution: A method for co-immobilizing glutamate decarboxylase and its coenzyme pyridoxal phosphate comprises the following steps: (1) Fe3O4@PDA covalently binds glutamate decarboxylase (GAD): Glutamate decarboxylase enzyme solution is added to Fe3O4@PDA magnetic nanoparticles to regulate the reaction p H is 7-9, and after sufficient stirring, Fe3O4@PDA@GAD nanoparticles are obtained through post-treatment; In this reaction, the phthalic acid groups on the surface of PDA react with the amino and sulfhydryl groups carried by the GAD enzyme molecules to undergo Michael addition reaction and Schiff base reaction to immobilize the enzyme; (2) Fe3O4@PDA@GAD grafted with polyethyleneimine and adsorbed with pyridoxal phosphate: polyethyleneimine solution and pyridoxal phosphate solution were added to Fe3O4@PDA@GAD nanoparticles to adjust the reaction p H is 7-10, after shaking incubation and post-treatment, the immobilized enzyme Fe3O4@PDA@PEI@GAD&PLP with glutamate decarboxylase and its coenzyme pyridoxal phosphate co-immobilized is obtained; In this reaction, Fe3O4@PDA@GAD nanoparticles are first used as carriers to graft PEI. Under weakly alkaline conditions, the remaining catechol groups on the surface of Fe3O4@PDA@GAD nanoparticles are oxidized into phthalocyanine, which then covalently bonds with the amino groups carried by PEI to wrap the Fe3O4@PDA nanoparticles with GAD fixed therein to obtain Fe3O4@PDA@GAD@PEI nanoparticles. Then, Fe3O4@PDA@GAD@PEI nanoparticles are used as carriers, and the negatively charged PLP is adsorbed by the electrostatic attraction of the large amount of positive charges carried on the surface of PEI, thereby achieving co-immobilization of GAD and its coenzyme PLP to obtain Fe3O4@PDA@PEI@GAD&PLP nanoparticles.
[0008] Furthermore, in step (1), the mass ratio of the Fe3O4@PDA magnetic nanoparticles to the glutamate decarboxylase enzyme solution is 20:(1.2-2.4).
[0009] Furthermore, the mass ratio of Fe3O4@PDA magnetic nanoparticles, polyethyleneimine solution and pyridoxal phosphate solution was 20:(10-30):(0.1-0.5).
[0010] Furthermore, the reaction of step (1) and step (2) p H is adjusted using phosphate buffer, wherein the reaction in step (1) p H is preferably 7. p H is preferably 8.5.
[0011] Furthermore, the post-treatment in step (1) and step (2) is to separate the mixture magnetically and then wash it with deionized water.
[0012] Furthermore, the Fe3O4@PDA magnetic nanoparticles in step (1) are prepared by conventional methods, preferably the following method: Fe3O4 nanoparticles were added to dopamine hydrochloride (DA) solution, and after sufficient stirring, the solution was washed, dried and ground in sequence to obtain Fe3O4@PDA magnetic nanoparticles.
[0013] Furthermore, the mass ratio of Fe3O4 nanoparticles to dopamine hydrochloride solution is preferably 1:2.
[0014] Furthermore, the above-mentioned Fe3O4 nanoparticles are prepared by chemical co-precipitation method.
[0015] The specific steps are as follows: adding ammonia water to the mixture of FeSO4 and FeCl3, water bathing, fully stirring, and then magnetic separation, washing, magnetic separation, drying, and grinding in sequence to obtain Fe3O4 magnetic nanoparticles; wherein, Fe 2+ with Fe3+ The molar ratio is preferably 6:5.
[0016] The present invention also provides the use of the immobilized enzyme Fe3O4@PDA@PEI@GAD&PLP prepared by the above method in the preparation of γ-aminobutyric acid.
[0017] The optimal catalytic temperature of the immobilized enzyme Fe3O4@PDA@PEI@GAD&PLP is 37°C. p H is 4.0.
[0018] Compared with the prior art, the present invention has the following beneficial effects: (1) The present invention constructs a PEI network on the surface of the Fe3O4@PDA@GAD carrier, and utilizes the positive charge carried by the amino group on the PEI surface to electrostatically adsorb the negatively charged PLP, thereby storing the PLP in the PEI network on the carrier surface, achieving the exchange of PLP between the GAD active site and the PEI network, and preventing the loss of the coenzyme PLP.
[0019] (2) The present invention co-immobilizes GAD and its coenzyme PLP, so that when GAD is used to prepare GABA, there is no need to add the coenzyme PLP in the subsequent reaction process. This not only avoids the loss of PLP and saves costs, but also overcomes the difficulty of subsequent separation and purification caused by exogenous addition of PLP, thereby increasing the economic feasibility of GABA in industrial production.
[0020] (3) The stability of the immobilized enzyme Fe3O4@PDA@PEI@GAD&PLP obtained after co-immobilization of GAD and its coenzyme PLP was greatly improved. After 10 cycles of use, it still retained 71% of the initial immobilized enzyme activity. BRIEF DESCRIPTION OF THE DRAWINGS
[0021] Figure 1 Magnetic properties (a) and redispersibility (b) of the immobilized enzyme Fe3O4@PDA@PEI@GAD&PLP prepared by the method of the present invention.
[0022] Figure 2 The laser confocal microscope characterization diagram of the immobilized enzyme Fe3O4@PDA@PEI@GAD&PLP prepared by the method of the present invention. Among them, Figure (a) shows the green fluorescence of the immobilized enzyme Fe3O4@PDA@PEI@GAD&PLP at 488 nm; Figure (b) shows the blue autofluorescence of PLP at 405-488 nm; Figure (c) shows the cyan fluorescence emitted by the immobilized enzyme Fe3O4@PDA@PEI@GAD&PLP after dual-wavelength scanning. DETAILED DESCRIPTION
[0023] The present invention will be further described below in conjunction with specific embodiments.
[0024] Example 1 (1) Preparation of Fe3O4: Fe3O4 nanoparticles were prepared by chemical coprecipitation method. The experimental method is as follows: ① Add 1.39 g FeSO4•7H2O and 1.622 g FeCl3•6H2O to 40 mL deionized water respectively and stir to dissolve. ② After dissolution, pour them into a three-necked flask in turn and mix them. Then add 6 mL of ammonia water (25%) dropwise and place them in a 90℃ water bath. Stir the mixture at 600 r / min for 30 min and then separate it by magnetic separation. Wash it four times with ethanol and four times with deionized water. Pour it into a crucible and separate it by magnetic separation. Dry it in a forced air drying oven at 60℃ for 2 h. Grind and collect the powder to obtain Fe3O4 nanoparticles.
[0025] (2) Preparation of Fe3O4@PDA: 200 mg of dopamine hydrochloride was added to 200 mL of phosphate buffer (100 mM, pH = 8.5) and ultrasonicated for 10 min. Then 100 mg of Fe3O4 nanoparticles was added and stirred at 250 r / min at room temperature for 12 h. The mixture was washed twice with deionized water to remove the residual dopamine, dried at 60 °C in a constant temperature drying oven for 4 h, and ground to collect the powder to obtain Fe3O4@PDA nanoparticles.
[0026] (3) Covalent binding of Fe3O4@PDA to glutamate decarboxylase: Weigh 20 mg of Fe3O4@PDA nanoparticles, add 0.6 mL of GAD enzyme solution (2 mg / mL), and then add phosphate buffer (pH 7.0, 100 mM) to a total volume of 2 mL. Incubate at 25 °C and 160 r / min for 2 h, separate by magnetic separation, and wash with water several times to obtain Fe3O4@PDA@GAD nanoparticles.
[0027] (4) Fe3O4@PDA grafted with PEI and adsorbed with PLP: 2 mL of phosphate buffer (pH 8.5, 100 mM) and 20 mg of PEI were added to the Fe3O4@PDA@GAD nanoparticles, and 1 mL of PLP (1 mM) solution was added. The mixture was shaken at 160 r / min at room temperature for 2 h. After magnetic separation, the mixture was washed twice with deionized water to remove the unreacted PEI and PLP, thereby obtaining Fe3O4@PDA@PEI@GAD&PLP nanoparticles.
[0028] The enzyme loading capacity of Fe3O4@PDA@PEI@GAD&PLP was measured to be 52.6 mg / g, and the enzyme activity was 51.1 U / mg.
[0029] Example 2 As in Example 1, Fe3O4 and Fe3O4@PDA nanoparticles were first prepared.
[0030] Then, 20 mg of Fe3O4@PDA nanoparticles were weighed into an EP tube, 0.9 mL of 2 mg / mL GAD enzyme solution was added, and phosphate buffer (pH 7.0, 100 mM) was added to a total volume of 2 mL. The mixture was reacted at 25 °C and 160 r / min for 2 h, magnetically separated, and washed with water several times to obtain Fe3O4@PDA@GAD nanoparticles.
[0031] Afterwards, 2 mL of phosphate buffer (pH 8.5, 100 mM) and 20 mg of PEI were added to the Fe3O4@PDA@GAD nanoparticles, and 1 mL of PLP (1 mM) solution was added at the same time. The mixture was shaken at 160 r / min at room temperature for 2 h. After magnetic separation, the mixture was washed twice with deionized water to remove the unreacted PEI and PLP to obtain Fe3O4@PDA@PEI@GAD&PLP nanoparticles.
[0032] The enzyme loading capacity of Fe3O4@PDA@PEI@GAD&PLP was measured to be 75.6 mg / g, and the enzyme activity was 59.9 U / mg.
[0033] Example 3 As in Example 1, Fe3O4 and Fe3O4@PDA nanoparticles were first prepared.
[0034] Then, 20 mg of Fe3O4@PDA nanoparticles were weighed into an EP tube, 1.2 mL of 2 mg / mL GAD enzyme solution was added, and phosphate buffer (pH 7.0, 100 mM) was added to a total volume of 2 mL. The mixture was reacted at 25 °C and 160 r / min for 2 h, magnetically separated, and washed with water several times to obtain Fe3O4@PDA@GAD nanoparticles.
[0035] Afterwards, 2 mL of phosphate buffer (pH 8.5, 100 mM) and 20 mg of PEI were added to the Fe3O4@PDA@GAD nanoparticles, and 1 mL of PLP (1 mM) solution was added at the same time. The mixture was shaken at 160 r / min at room temperature for 2 h. After magnetic separation, the mixture was washed twice with deionized water to remove the unreacted PEI and PLP to obtain Fe3O4@PDA@PEI@GAD&PLP nanoparticles.
[0036] The enzyme loading capacity of Fe3O4@PDA@PEI@GAD&PLP was measured to be 97.4 mg / g, and the enzyme activity was 51.5 U / mg.
[0037] Example 4 As in Example 1, Fe3O4 and Fe3O4@PDA nanoparticles were first prepared.
[0038] Then, 20 mg of Fe3O4@PDA nanoparticles were weighed into an EP tube, 1.5 mL of 2 mg / mL GAD enzyme solution was added, and phosphate buffer (pH 7.0, 100 mM) was added to a total volume of 2 mL. The mixture was reacted at 25 °C and 160 r / min for 2 h, magnetically separated, and washed with water several times to obtain Fe3O4@PDA@GAD nanoparticles.
[0039] Afterwards, 2 mL of phosphate buffer (pH 8.5, 100 mM) and 20 mg of PEI were added to the Fe3O4@PDA@GAD nanoparticles, and 1 mL of PLP (1 mM) solution was added at the same time. The mixture was shaken at 160 r / min at room temperature for 2 h. After magnetic separation, the mixture was washed twice with deionized water to remove the unreacted PEI and PLP to obtain Fe3O4@PDA@PEI@GAD&PLP nanoparticles.
[0040] The enzyme loading capacity of Fe3O4@PDA@PEI@GAD&PLP was measured to be 101.1 mg / g, and the enzyme activity was 45.3 U / mg.
[0041] By comparing the enzyme loading and enzyme activity data of the immobilized enzyme Fe3O4@PDA@PEI@GAD&PLP prepared in Example 4 with those in Examples 1-3, it can be found that when the amount of GAD enzyme added is too large, the enzyme activity recovery rate will be greatly reduced, which is not conducive to enzyme saving.
[0042] Example 5 Magnetic Responsivity and Redispersibility The immobilized enzyme Fe3O4@PDA@PEI@GAD&PLP was prepared according to the method of Example 1. The magnetic responsiveness of the product Fe3O4@PDA@PEI@GAD&PLP obtained by co-immobilizing GAD and its coenzyme PLP with Fe3O4@PDA@PEI was measured by a vibrating sample magnetometer. The results are as follows: Figure 1 As shown in a. It can be seen that the saturation magnetization intensity of Fe3O4@PDA@PEI@GAD&PLP is 49.21 emu / g, and the hysteresis loop passes through the zero point, showing superparamagnetism. Superparamagnetism will make Fe3O4@PDA@PEI@GAD&PLP easy to separate from the reaction solution, achieving the purpose of enzyme recovery and reuse.
[0043] Fe3O4@PDA@PEI@GAD&PLP was dispersed in aqueous solution, and the redispersibility was investigated by adding or removing magnets. The results are as follows Figure 1As shown in b. As can be seen from the figure, after the magnet is added, Fe3O4@PDA@PEI@GAD&PLP is quickly adsorbed by the magnet (5s), and the aqueous solution becomes clear. After the magnet is removed, the Fe3O4@PDA@PEI@GAD&PLP is gently shaken and it is evenly dispersed in the water again, showing good dispersibility.
[0044] It can be seen that Fe3O4@PDA@PEI@GAD&PLP has good magnetic responsiveness and redispersibility.
[0045] Example 6 Confocal laser scanning microscopy Glutamate decarboxylase GAD was labeled with the fluorescent indicator FITC, and Fe3O4@PDA@PEI@GAD&PLP was prepared according to the method of Example 1. The fluorescence characterization results of the immobilized enzyme Fe3O4@PDA@PEI@GAD&PLP are shown in Figure 2 As shown in the figure, it can be seen that Fe3O4@PDA@PEI@GAD&PLP exhibits green fluorescence at 488 nm, indicating that GAD is successfully fixed on the carrier (Figure a); at the same time, blue spontaneous fluorescence of PLP appears at 405-488 nm, indicating the presence of PLP (Figure b); after dual-wavelength scanning, it was found that the green fluorescence overlapped with the blue fluorescence, cyan fluorescence appeared, and the luminescent areas were all in the same position (Figure c).
[0046] The above results indicate that GAD and its coenzyme PLP were co-immobilized on the surface of Fe3O4@PDA@PEI nanoparticles, and Fe3O4@PDA@PEI@GAD&PLP was successfully prepared.
[0047] Example 7 Take 20 mg of immobilized enzyme Fe3O4@PDA@PEI@GAD&PLP, add 1 mL of sodium L-glutamate solution (50 mM), mix well, shake at 37°C and 120 r / min for 0.5 h. After the reaction, measure the yield of GABA. Then magnetically separate the immobilized enzyme, repeat the above operation for 10 consecutive measurements. The enzyme activity measured in the first cycle was counted as 100%, and the enzyme activity of subsequent cycles was expressed as a percentage of the first cycle. Three groups were measured in parallel for each experiment. It was found that the immobilized enzyme Fe3O4@PDA@PEI@GAD&PLP still retained 71% of the initial enzyme activity after 10 cycles.
Claims
1. A method for co-immobilizing glutamate decarboxylase and its coenzyme pyridoxal phosphate, characterized in that: The following steps are involved: (1) Covalent binding of glutamate decarboxylase to Fe3O4@PDA magnetic nanoparticles: Add glutamate decarboxylase enzyme solution to Fe3O4@PDA magnetic nanoparticles to regulate the reaction p H is 7-9, and after sufficient stirring, Fe3O4@PDA@GAD nanoparticles are obtained through post-treatment; (2) Fe3O4@PDA@GAD grafted with polyethyleneimine and adsorbed with pyridoxal phosphate: polyethyleneimine solution and pyridoxal phosphate solution were added to Fe3O4@PDA@GAD nanoparticles to adjust the reaction p H is 7-10. After shaking incubation and post-treatment, the immobilized enzyme Fe3O4@PDA@PEI@GAD&PLP is obtained.
2. The method for co-immobilizing glutamate decarboxylase and its coenzyme pyridoxal phosphate according to claim 1, characterized in that: In step (1), the mass ratio of the Fe3O4@PDA magnetic nanoparticles to the glutamate decarboxylase enzyme solution is 20:(1.2-2.4).
3. The method for co-immobilizing glutamate decarboxylase and its coenzyme pyridoxal phosphate according to claim 1, characterized in that: The reaction of step (1) and step (2) p H was adjusted with phosphate buffer.
4. The method for co-immobilizing glutamate decarboxylase and its coenzyme pyridoxal phosphate according to claim 1, characterized in that: The mass ratio of Fe3O4@PDA magnetic nanoparticles, polyethyleneimine solution and pyridoxal phosphate solution is 20:(10-30):(0.1-0.5).
5. The method for co-immobilizing glutamate decarboxylase and its coenzyme pyridoxal phosphate according to claim 1, characterized in that: The post-treatment is to separate the mixture magnetically and then wash it with deionized water.
6. The method for co-immobilizing glutamate decarboxylase and its coenzyme pyridoxal phosphate according to claim 1, characterized in that: The preparation method of the Fe3O4@PDA magnetic nanoparticles in step (1) is as follows: Fe3O4 nanoparticles are added to a dopamine hydrochloride solution, and after sufficient stirring, the solution is washed, dried, and ground in sequence to obtain Fe3O4@PDA magnetic nanoparticles.
7. The method for co-immobilizing glutamate decarboxylase and its coenzyme pyridoxal phosphate according to claim 6, characterized in that: The mass ratio of Fe3O4 nanoparticles to dopamine hydrochloride solution is 1:
2.
8. Use of the immobilized enzyme Fe3O4@PDA@PEI@GAD&PLP prepared by the method of co-immobilizing glutamate decarboxylase and its coenzyme pyridoxal phosphate as described in claim 1 in the preparation of γ-aminobutyric acid.
9. The use according to claim 8, characterized in that: The catalytic temperature of the immobilized enzyme Fe3O4@PDA@PEI@GAD&PLP is 37°C. p H is 4.0.
